| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | See Remarks
1 company
Goldberg Itzhak is a Director at ELTX. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $1.9M at current prices.
Our model assigns Goldberg Itzhak a strong insider score of 85/100, based on 6 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +76.2%.
Goldberg Itzhak's largest disclosed position is in ELTX as Director, worth about $1.9M. The recent filings there lean toward selling, a net 300,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 32,118 | $3.35 | $107,720.56 | -1.8% | -45.6% | -75.1% | |
| Dec 3, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 117,882 | $3.48 | $410,210.84 | -6.3% | -41.9% | -72.5% | |
| Nov 16, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 150,000 | $4.19 | $629,051.24 | -7.4% | -49.4% | -79.4% |